vimarsana.com
Home
Live Updates
NightHawk Biosciences Announces Planned Name Change to Scorp
NightHawk Biosciences Announces Planned Name Change to Scorp
NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMO
Announces senior leadership appointments to further support client programs and growing sales pipelineDURHAM, N.C., Jan. 08, 2024 -- NightHawk Biosciences , an integrated contract development and...
Related Keywords
Texas ,
United States ,
Lagos ,
Nigeria ,
Warsaw ,
L67 ,
Poland ,
San Antonio ,
American ,
Brian Omara ,
Jeff Wolf ,
Catalent Biologics ,
Ania Szymanska ,
Steve Lavezoli ,
David Waldman ,
Marker Therapeutics Inc ,
Quality Validation Specialists Of Opexa Therapeutics Inc ,
Company To Scorpius Holdings Inc ,
Quality Control For Bellicum Pharmaceuticals Inc ,
University Of Warsaw ,
Bristol Myers Squibb ,
Business Market Development ,
Suspension Process Development At Rocket Pharmaceuticals ,
Quality Control Department ,
Scorpius Holdings ,
Twitter ,
Robert Morris University ,
Lehigh University ,
Manufacturing Science Technology ,
Binghamton University ,
Rutgers University ,
Business Development ,
Pennsylvania State University ,
Woodfield Pharmaceutical ,
Nighthawk Biosciences Inc ,
Pernix Manufacturing ,
Drug Substance Business Development ,
Hawk Biosciences ,
Scorpius Biomanufacturing ,
Briano Mara ,
Process Sciences ,
Commercial Operations ,
Juan Lagos ,
Senior Director ,
Cell Based Technologies ,
Site Head ,
Manufacturing Science ,
Linde Gas ,
Startup Biopharmaceutical ,
Market Development ,
Bulk Drug Substance Single Use ,
Chemical Engineering ,
Robert Morris ,
Associate Director ,
Process Development ,
Wuxi Apptec ,
Computer Science ,
Quality Control ,
Quality Assurance ,
Marker Therapeutics ,
Vice President ,
Quality Management ,
Bellicum Pharmaceuticals ,
Quality Validation Specialists ,
Opexa Therapeutics ,
Private Securities Litigation Reform Act ,
Investor Relations ,
Markets ,